Index Ventures II raises $191m at first closing

The fund is targeting $300m and expects to announce a final closing during the first quarter of 2001.

Index Ventures, the Geneva-based European venture capital fund, has raised $191m at first closing of its fund, Index Ventures II. A second and final closing of the fund, which aims to raise $300m, is expected within the first quarter of 2001.

New investors include Oracle Corporation, HarbourVest, Azeo (Lazard), Spelman College, Oberlin College and Frank Russell Associates. Cisco Systems, Invesco, UBS Capital, Standard Life, Liechtenstein Global Trust, Partners Group, VCM (Munich) and Proventure have made return investments.

The firm has also appointed Francesco De Rubertis, PhD, partner. Dr. De Rubertis, who joined the firm in 1997 to build the firm's life science investment practice, has supported investments in Index portfolio companies GeneBio, GeneProt, Structural GenomiX, Genmab and Ingenium.

Index Ventures is a pan-European venture capital firm which focuses on information technology and health care. Portfolio companies which have been listed include SCM Microsystems, Virata, Evolve Software, StepStone, Numerical Technologies and Genmab.

Index Ventures raised $180 million and has now been fully invested.